Lacosamide safe, efficacious for long-term seizure control in idiopathic generalized epilepsy
In patients with idiopathic generalized epilepsy, adjunctive lacosamide treatment in the long term may safely reduce the frequency of generalized onset tonic–clonic seizures (GTCS), as shown in the open-label extension EP0012 trial.
Lacosamide safe, efficacious for long-term seizure control in idiopathic generalized epilepsy
31 Oct 2024